Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05059262 |
| Title | Phase 3 Study of Vimseltinib for Tenosynovial Giant Cell Tumor (MOTION) |
| Acronym | MOTION |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Deciphera Pharmaceuticals LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL | NOR | NLD | ITA | GBR | FRA | ESP | DEU | CHE | CAN | AUS |